CLASS II Drug recall · Reported 15 Jun 2016 · FDA Enforcement Report

Chlorhexidine Gluco recalled by Aidarex Pharmaceuticals

Aidarex Pharmaceuticals is recalling Chlorhexidine Gluco, distributed in California, North Dakota, Pennsylvania, Tennessee. The recall was initiated on 1 Jun 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: 45335-1, Expiry: 2017/02; Lot #: 46807-1, Expiry: 2017/01; Lot #: 44359-1, Expiry: 2017/02; Lot #: 44395-1, Expiry: 2017/02; Lot #: 44693-1, Expiry: 2017/02; Lot #: 44694-1, Expiry: 2017/02; Lot #: 43707-1, Expiry: 2017/03; Lot #: 47697-1, Expiry: 2017/03; Lot #: 48605-1, Expiry: 2017/03; Lot #: 48659-1, Expiry: 2017/03; Lot #: 47772-1, Expiry: 2017/05; Lot #: 48271-1, Expiry: 2017/05.
Quantity recalled292 Bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0975-2016
FDA event ID
74315
Recalling firm
Aidarex Pharmaceuticals, Corona, CA
Classification
Class II
Status
Terminated
Recall initiated
1 Jun 2016
FDA classified
8 Jun 2016
Reported
15 Jun 2016
Type
Voluntary: Firm initiated
Customers notified by
FAX
Reason category
Potency & Assay

Timeline

1 Jun 2016Recall initiated by company
8 Jun 2016Classified by FDA+7 days
15 Jun 2016Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Impurity/Degradation Specifications: Out of specifications for unknown impurity.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

CHLORHEXIDINE GLUCO. 0.12% ORAL RINSE, Packaged in 473 ML Bottles, Rx Only. MFG: HI-TECH PHARMACAL CO., INC., AMITYVILLE, NY 11701, Packaged By: Aidarex PHARMACEUTICALS. NDC: 33261-0447-01.

Where it was distributed

U.S. including: CA, ND, PA, TN

CaliforniaNorth DakotaPennsylvaniaTennessee

Questions about this recall

Why was it recalled?

Failed Impurity/Degradation Specifications: Out of specifications for unknown impurity.

Which lots are affected?

Lot #: 45335-1, Expiry: 2017/02; Lot #: 46807-1, Expiry: 2017/01; Lot #: 44359-1, Expiry: 2017/02; Lot #: 44395-1, Expiry: 2017/02; Lot #: 44693-1, Expiry: 2017/02; Lot #: 44694-1, Expiry: 2017/02; Lot #: 43707-1, Expiry: 2017/03; Lot #: 47697-1, Expiry: 2017/03; Lot #: 48605-1, Expiry: 2017/03; Lot #: 48659-1, Expiry: 2017/03; Lot #: 47772-1, Expiry: 2017/05; Lot #: 48271-1, Expiry: 2017/05.

Where was it sold?

U.S. including: CA, ND, PA, TN

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Aidarex Pharmaceuticals

All 10